[{"internal_id": 155227943, "Award ID": "W912HZ2320007", "Award Amount": 87000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-12-13", "CFDA Number": "12.360", "Description": "ASSESSMENT OF HISTORICAL AND CURRENT REGIONAL GEOMORPHIC PARAMETERS IN OZARK STREAMS TO SUPPORT BANK STABILIZATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "521d6dad-4cec-d101-43b1-01a1438fe39e-C", "generated_internal_id": "ASST_NON_W912HZ2320007_2100"}, {"internal_id": 89793054, "Award ID": "W912HZ1920029", "Award Amount": 281037.16, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-09-24", "CFDA Number": "12.360", "Description": "EXPLORATORY ANALYSIS AND INTERACTIVE WORKFLOWS FOR NUMERICAL MODELING AND VISUALIZATION OF FLOOD SIMULATION", "Place of Performance Country Code": "FRA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1621125d-3efd-0977-6bb4-d607596c453d-C", "generated_internal_id": "ASST_NON_W912HZ1920029_2100"}, {"internal_id": 62671384, "Award ID": "W912HZ1820002", "Award Amount": 354700.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2018-02-22", "CFDA Number": "12.630", "Description": "COASTAL BEND STUDY AREA HURRICANE EVACUATION STUDY BEHAVIORAL RESPONSE, EVACUATION ZONE DEVELOPMENT, VULNERABILITY AND TRANSPORTATION ANALYSIS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6e8af14f-f2e4-f022-424a-eb4073111a36-C", "generated_internal_id": "ASST_NON_W912HZ1820002_2100"}, {"internal_id": 50163674, "Award ID": "W912HZ1420024", "Award Amount": 183613.24, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-18", "CFDA Number": "12.630", "Description": "WADING BIRD COLONY LOCATION, SIZE, AND TIMING IN LAKE OKEECHOBEE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "caef8c38-5944-9743-df26-1aeaf8b6bc50-C", "generated_internal_id": "ASST_NON_W912HZ1420024_2100"}, {"internal_id": 50163672, "Award ID": "W912HZ1420023", "Award Amount": 192495.56, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-22", "CFDA Number": "12.630", "Description": "LANDSCAPE PATTERN - MARL PRAIRIE/SLOUGH GRADIENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8521f543-2302-80cf-d989-c2ff7cf07ef3-C", "generated_internal_id": "ASST_NON_W912HZ1420023_2100"}, {"internal_id": 50163670, "Award ID": "W912HZ1420022", "Award Amount": 184936.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-22", "CFDA Number": "12.360", "Description": "MONITORING OF TREE ISLAND CONDITION IN THE SOUTHERN EVERGLADES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8521f543-2302-80cf-d989-c2ff7cf07ef3-C", "generated_internal_id": "ASST_NON_W912HZ1420022_2100"}, {"internal_id": 143708395, "Award ID": "W911W62220001", "Award Amount": 2637848.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-11-18", "CFDA Number": "12.360", "Description": "ADAPTIVE RESILIENT ENGINEERED STRUCTURES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d64537c9-5482-dd40-cdd4-5cf07b66329d-C", "generated_internal_id": "ASST_NON_W911W62220001_2100"}, {"internal_id": 138391969, "Award ID": "W911QY2120001", "Award Amount": 450000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-02-17", "CFDA Number": "12.360", "Description": "COOPERATIVE AGREEMENT FOR RESEARCH AND DEVELOPMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d4b0ff0c-e3a2-f597-7ab0-1c78e1010874-C", "generated_internal_id": "ASST_NON_W911QY2120001_2100"}, {"internal_id": 110801471, "Award ID": "W911QY2020005", "Award Amount": 12475835.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2020-09-24", "CFDA Number": "12.360", "Description": "COOPERATIVE AGREEMENT FOR RESEARCH AND DEVELOPMENT - SLIMMER3", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0f7fcd53-a62a-0ccf-e3e6-c6b54ddb6fd2-C", "generated_internal_id": "ASST_NON_W911QY2020005_2100"}, {"internal_id": 110753182, "Award ID": "W911QY2010005", "Award Amount": 135000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-17", "CFDA Number": "12.360", "Description": "GRANT FOR R&D - DEVELOPMENT OF A HUMAN ENTEROID-IMMUNE CO-CULTURE MODEL", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e895f676-c226-223f-b5ed-dda80c2ec73a-C", "generated_internal_id": "ASST_NON_W911QY2010005_2100"}, {"internal_id": 50160732, "Award ID": "W911QY1620002", "Award Amount": -31.76, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-11-06", "CFDA Number": "12.355", "Description": "NO COST EXTENSION, END DATE CHANGED FROM 1 NOV 2017 TO 1 MAY 2018", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a8ad38bc-2827-1399-cd46-c5204062852b-C", "generated_internal_id": "ASST_NON_W911QY1620002_2100"}, {"internal_id": 50160724, "Award ID": "W911QY1610006", "Award Amount": 527661.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-04-28", "CFDA Number": "12.360", "Description": "UTILITY OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1610006_2100"}, {"internal_id": 70342627, "Award ID": "W911QY1610004", "Award Amount": 72872.19, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-28", "CFDA Number": "12.360", "Description": "ADD $75K IN FUNDING AND COST FOR ADDITIONAL EFFORT EXTEND COMPLETION DATE FROM 04/03/2019 TO 09/27/2019", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1610004_2100"}, {"internal_id": 50160720, "Award ID": "W911QY1610003", "Award Amount": 494013.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-02-22", "CFDA Number": "12.360", "Description": "ADDITIONAL PEDOPED STUDIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1610003_2100"}, {"internal_id": 50160718, "Award ID": "W911QY1610002", "Award Amount": 0.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-28", "CFDA Number": "12.360", "Description": "CORRECT LINE OF ACCOUNTING INFORMATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1610002_2100"}, {"internal_id": 50160716, "Award ID": "W911QY1610001", "Award Amount": 508955.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-12-21", "CFDA Number": "12.355", "Description": "GRANT AMENDMENT TO CHANGE PI AND COMPLETION DATE FOR EFFORTS 'INSECT BITE-PROOF TEXTILES FOR MILITARY UNIFORMS'. ADDS $95K", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d4b0ff0c-e3a2-f597-7ab0-1c78e1010874-C", "generated_internal_id": "ASST_NON_W911QY1610001_2100"}, {"internal_id": 111008938, "Award ID": "W911QY1520004", "Award Amount": 166395.58, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-03", "CFDA Number": "12.360", "Description": "CLINICAL UTILITIES AND PITFALLS OF ULTRASOUND GUIDED FOREIGN BODY REMOVAL***", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "24042a1a-03ec-326e-b5c2-89242d7c209d-C", "generated_internal_id": "ASST_NON_W911QY1520004_2100"}, {"internal_id": 50160711, "Award ID": "W911QY1510019", "Award Amount": 1965000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-12-01", "CFDA Number": "12.360", "Description": "INCREMENTAL FUNDING $495K", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6ad8c5c3-8085-49bb-9227-fc5bc4a1f938-C", "generated_internal_id": "ASST_NON_W911QY1510019_2100"}, {"internal_id": 50160709, "Award ID": "W911QY1510018", "Award Amount": -231.11, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-09", "CFDA Number": "12.360", "Description": "THE EFFECT OF A BRIEF PAIN MEDICATION EDUCATIONAL VIDEO BEFORE LUMBAR SURGERY ON 6-MONTH POST-OPERATIVE USE OF OPIOID MEDICATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1510018_2100"}, {"internal_id": 50160707, "Award ID": "W911QY1510017", "Award Amount": 0.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-09", "CFDA Number": "12.360", "Description": "USING MOBILE TECHNOLOGY AT THE POINT OF CARE TO INFLUENCE HEALTHCARE TREATMENT DECISIONS RELATED TO LOW BACK PAIN MANAGEMENT IN PRIMARY CARE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1510017_2100"}, {"internal_id": 50160705, "Award ID": "W911QY1510016", "Award Amount": 0.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-09", "CFDA Number": "12.360", "Description": "SURGICAL OUTCOMES FOR FEMORACETABULAR IMPINGEMENT (SOF STUDY)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1510016_2100"}, {"internal_id": 50160703, "Award ID": "W911QY1510015", "Award Amount": -10774.44, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-06-14", "CFDA Number": "12.360", "Description": "REAL TIME BIO-FEEDBACK DURING RUNNING REHABILITATION EXTEND GRANT END DATE FROM TO 31 AUG 2016 TO 31 AUG 2017, AT NO ADDITIONAL COST.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3e4caa6c-ea4b-e402-0001-860fad11861b-C", "generated_internal_id": "ASST_NON_W911QY1510015_2100"}, {"internal_id": 50160701, "Award ID": "W911QY1510014", "Award Amount": 500000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-03", "CFDA Number": "12.360", "Description": "FUNDING ACTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "42107c5f-70fa-42eb-9219-6a769d9617e9-C", "generated_internal_id": "ASST_NON_W911QY1510014_2100"}, {"internal_id": 107978226, "Award ID": "W911QY1510012", "Award Amount": 226501.28, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-08-03", "CFDA Number": "12.360", "Description": "FEASIBILITY OF ACCELEROMETRY TO DISCRIMINATE ALTERATIONS IN POSTURAL CONTROL FOLLOWING VESTIBULAR INSULT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1510012_2100"}, {"internal_id": 50160697, "Award ID": "W911QY1510011", "Award Amount": -14923.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-22", "CFDA Number": "12.360", "Description": "PERFORMANCE TRIAD: OUTCOMES OF IMPLEMENTING A TEAM FOCUSED, EVIDENCE BASED AND VALIDATED COMPREHENSIVE COTS PROGRAM USING WEB-BASED AND MOBILE DEVICE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1510011_2100"}, {"internal_id": 50160695, "Award ID": "W911QY1510010", "Award Amount": -763.65, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-08-22", "CFDA Number": "12.360", "Description": "USING STRUCTURAL HEALTH MONITORING TO IMPROVE DIAGNOSIS AND TREATMENT OF CHRONIC PAIN IN US SERVICE MEMBERS, NO COST EXTENSION FROM 09/14/2017 TO 03/", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1510010_2100"}, {"internal_id": 110190435, "Award ID": "W911QY1510009", "Award Amount": 144784.92, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2015-07-28", "CFDA Number": "12.360", "Description": "EVALUATION OF A RUNNING SOCK DESIGNED TO PROVIDE REAL TIME BIOFEEDBACK TO HEALTHY U.S. SERVICE MEMBERS AWARDED 28 JUL 2015, ACTION DID NOT APPEAR TO TRANSFER FROM DAADS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1510009_2100"}, {"internal_id": 50160683, "Award ID": "W911QY1510002", "Award Amount": 520934.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2016-05-09", "CFDA Number": "12.360", "Description": "INSECT BITE PROOF TEXTILES FOR MILITARY UNIFORMS", "Place of Performance Country Code": "TZA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5b0a9541-2e2b-ceaf-ed52-f73b83606f1b-R", "generated_internal_id": "ASST_NON_W911QY1510002_2100"}, {"internal_id": 50160678, "Award ID": "W911QY1410005", "Award Amount": 167247.0, "Award Type": null, "Base Obligation Date": "2014-09-11", "CFDA Number": "12.360", "Description": "EVALUATION OF THE EFFICACY OF A NOVEL SOFT-TISSUE CLAMP FOR HASTY COMPRESSIBLE HEMORRHAGE CONTROL VERSUS TOURNIQUET APPLICATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c0534dd6-007b-cfc7-2a77-9b3602a48251-C", "generated_internal_id": "ASST_NON_W911QY1410005_2100"}, {"internal_id": 50160677, "Award ID": "W911QY1410003", "Award Amount": 227067.46, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2014-09-12", "CFDA Number": "12.360", "Description": "EXTEND GRANT TERM END DATE FROM 31 MAR 2018 TO 30 SEP 2018, AT NO ADDITIONAL COST.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e493ceb6-e32b-aff1-1252-7a4c7f60e265-C", "generated_internal_id": "ASST_NON_W911QY1410003_2100"}, {"internal_id": 95572623, "Award ID": "W911NF1920056", "Award Amount": 433302.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-01-14", "CFDA Number": "12.360", "Description": "COOPERATIVE AGREEMENT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c6d4e6a-e5c4-b348-571b-42f4d585f5a8-C", "generated_internal_id": "ASST_NON_W911NF1920056_2100"}, {"internal_id": 154084218, "Award ID": "W58P052220014", "Award Amount": 22482436.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-18", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. NEW COOPERATIVE AGREEMENT. INDUSTRIAL BASE EXPANSION CONSUMABLES PORTFOLIO FOR VIALS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9337707-8b3b-e88a-6b7d-008d26651a4b-C", "generated_internal_id": "ASST_NON_W58P052220014_2100"}, {"internal_id": 154084264, "Award ID": "W58P052220013", "Award Amount": 45197817.19, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-09-13", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. SUSTAINMENT OF CRITICAL PRODUCTION OF ADVANCED, HIGH-QUALITY PHARMACEUTICAL GLASS TUBING AND VIALS TO CREATE AND MAINTAIN INDUSTRIAL BASE CAPABILITIES ESSENTIAL FOR NATIONAL DEFENSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "78f740eb-6c12-3689-da44-c0653982eb17-C", "generated_internal_id": "ASST_NON_W58P052220013_2100"}, {"internal_id": 154084317, "Award ID": "W58P052220012", "Award Amount": 34373104.8, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-05-27", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. ADDITION OF TWO BIOSAFETY LEVEL 1 (BSL1) FILL/FINISH LINES TO JUBILANT HOLLISTERSTIER LLC, SPOKANE, WA FACILITY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "60a6f4ac-b0c5-012e-f21b-839d73c9d967-C", "generated_internal_id": "ASST_NON_W58P052220012_2100"}, {"internal_id": 154084288, "Award ID": "W58P052220010", "Award Amount": 28153323.06, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-05-18", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. CA FOR IBX (RIBONUCLEOTIDE TRIPHOSPHATES (NTPS))", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2e43c792-d354-baf6-8c52-35b483d197fd-C", "generated_internal_id": "ASST_NON_W58P052220010_2100"}, {"internal_id": 154084301, "Award ID": "W58P052220009", "Award Amount": 40402738.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-05-05", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. INDUSTRIAL BASE EXPANSION COOPERATIVE AGREEMENT TO EXELA PHARMA SCIENCES, LLC (EXELA)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ee5ce4f0-acd4-2c11-0aa9-964ac7abd1c9-C", "generated_internal_id": "ASST_NON_W58P052220009_2100"}, {"internal_id": 154084232, "Award ID": "W58P052220008", "Award Amount": 32795538.5, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-08-03", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. DOMESTIC VIAL MANUFACTURING.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4a706bc2-4e75-c45b-b20c-50b5e0acd6e0-C", "generated_internal_id": "ASST_NON_W58P052220008_2100"}, {"internal_id": 154084298, "Award ID": "W58P052220007", "Award Amount": 37820473.46, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-04-25", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. NEW COOPERATIVE AGREEMENT FOR THE EXPANSION OF GRAND RIVER ASEPTIC MANUFACTURING, INC. (GRAM) DOMESTIC ASEPTIC FILL/FINISH CAPACITY TO MEET THE UNITED STATES GOVERNMENT (USG) REQUIREMENTS OF BEING ABLE TO FILL A BROAD RANGE OF VACCINES AND ESSENTIAL MEDICINES RAPIDLY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0990861f-3efb-dd35-e93b-d8e8217173d5-C", "generated_internal_id": "ASST_NON_W58P052220007_2100"}, {"internal_id": 154084312, "Award ID": "W58P052220006", "Award Amount": 4234070.22, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-05-20", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. INDUSTRIAL BASE EXPANSION OF CAPACITY FOR THE MANUFACTURE OF LIPIDS UTILIZED IN LIPID NANOPARTICLES (LNP) TECHNOLOGY FOR COVID VACCINES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b5590a5d-aba6-bb19-26da-ad6a67fc2a43-C", "generated_internal_id": "ASST_NON_W58P052220006_2100"}, {"internal_id": 154084306, "Award ID": "W58P052220005", "Award Amount": 47242206.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-02-25", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. EXPANSION OF VIAL PRODUCTION TO CREATE INDUSTRIAL BASE CAPABILITIES FOR NATIONAL DEFENSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f0815675-bea6-6028-0d15-fe4baaafa215-C", "generated_internal_id": "ASST_NON_W58P052220005_2100"}, {"internal_id": 154084293, "Award ID": "W58P052220004", "Award Amount": 13214795.45, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-03-03", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. EXPAND AND ACCELERATE DOMESTIC MANUFACTURING RELATED TO MEDICAL, CHEMICAL AND BIOLOGICAL COUNTERMEASURES OF FILL/FINISH PRODUCTION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f3519a96-cdea-da2d-b3f7-217adeab3d7c-C", "generated_internal_id": "ASST_NON_W58P052220004_2100"}, {"internal_id": 158863838, "Award ID": "W58P052220003", "Award Amount": 0.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2023-02-14", "CFDA Number": "12.360", "Description": "RESEARCH ON CHEMICAL AND BIOLOGICAL DEFENSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d3cf9ec-ca04-d3b6-9c07-777e3544155a-C", "generated_internal_id": "ASST_NON_W58P052220003_9763"}, {"internal_id": 154084315, "Award ID": "W58P052220003", "Award Amount": 30775490.77, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-01-21", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. EXPANSION OF VIAL PRODUCTION TO CREATE INDUSTRIAL BASE CAPABILITIES FOR NATIONAL DEFENSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d3cf9ec-ca04-d3b6-9c07-777e3544155a-C", "generated_internal_id": "ASST_NON_W58P052220003_2100"}, {"internal_id": 154084314, "Award ID": "W58P052220002", "Award Amount": 10332628.05, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-06-17", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. INDUSTRIAL BASE EXPANSION (IBX) OF CAPACITY FOR THE MANUFACTURE OF LIPIDS USED IN LIPID NANO PARTICLE (LNP) TECHNOLOGY FOR COVID-19 VACCINES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8def16a0-5bb1-c968-857b-2ae9adf1d03a-R", "generated_internal_id": "ASST_NON_W58P052220002_2100"}, {"internal_id": 154503002, "Award ID": "W58P052220001", "Award Amount": 89998664.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-11-12", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. ESTABLISHMENT AND SUSTAINMENT OF BSL 2 STERILE FILL/FINISH PRODUCTION CAPACITY TO CREATE AND MAINTAIN INDUSTRIAL BASE CAPABILITIES FOR NATIONAL DEFENSE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4be6f2ac-b163-b4a2-72c0-bf00df5e393f-C", "generated_internal_id": "ASST_NON_W58P052220001_2100"}, {"internal_id": 156877875, "Award ID": "HQ00342110002", "Award Amount": 1500000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-04-05", "CFDA Number": "12.360", "Description": "FOUNDATIONS OF SOCIAL INFORMATION DYNAMICS AND CONTROL PROJECT.", "Place of Performance Country Code": "USA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2c3d8c8a-27ef-b1e9-7164-bbfa490faa27-C", "generated_internal_id": "ASST_NON_HQ00342110002_97F5"}, {"internal_id": 101790104, "Award ID": "W911SR2030005", "Award Amount": 20034683.29, "Award Type": "OTHER REIMBURSABLE, CONTINGENT, INTANGIBLE, OR INDIRECT FINANCIAL ASSISTANCE", "Base Obligation Date": "2020-07-11", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. EXPANDING DOMESTIC PRODUCTION OF NEEDLES AND SYRINGES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": 20663774.0, "Infrastructure Obligations": null, "recipient_id": "8290e6d4-59cf-e1a2-c39b-137abf63c462-C", "generated_internal_id": "ASST_NON_W911SR2030005_2100"}, {"internal_id": 98553768, "Award ID": "W911SR2030001", "Award Amount": 36273957.39, "Award Type": "OTHER REIMBURSABLE, CONTINGENT, INTANGIBLE, OR INDIRECT FINANCIAL ASSISTANCE", "Base Obligation Date": "2020-07-01", "CFDA Number": "12.360", "Description": "COVID-19 ACTION. TECHNOLOGY INVESTMENT AGREEMENT FOR EXPANDING DOMESTIC PRODUCTION OF NEEDLES AND SYRINGES IN ACCORDANCE WITH (IAW) RECIPIENT PROPOSAL DATED 25 JUN 2020", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": 42303230.0, "Infrastructure Obligations": null, "recipient_id": "7ffb5454-2878-79bf-e6ce-ed744cbd0f74-C", "generated_internal_id": "ASST_NON_W911SR2030001_2100"}, {"internal_id": 98311399, "Award ID": "W911QY2030002", "Award Amount": 49189401.5, "Award Type": "OTHER REIMBURSABLE, CONTINGENT, INTANGIBLE, OR INDIRECT FINANCIAL ASSISTANCE", "Base Obligation Date": "2020-06-12", "CFDA Number": "12.360", "Description": "TECHNOLOGY INVESTMENT AGREEMENT FOR STRATEGIC ASEPTIC FILL ENVIRONMENTS IN THE UNITED STATES (SAFE-US) IAW VENDOR PROJECT PLAN DATED 8 JUNE 2020 TO PURSUE EXPANSION OF RECIPIENT'S EXISTING FILL-FINISH CAPACITIES TO SUPPORT RESEARCH IN PURSUIT OF DOMESTIC DEVELOPMENT AND DISTRIBUTION OF A VACCINE IN RESPONSE TO THE WORLDWIDE COVID-19 PANDEMIC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "54b497d1-b582-3771-349d-29b0219a0136-C", "generated_internal_id": "ASST_NON_W911QY2030002_2100"}, {"internal_id": 111009070, "Award ID": "W911NF2130001", "Award Amount": 180174623.0, "Award Type": "OTHER REIMBURSABLE, CONTINGENT, INTANGIBLE, OR INDIRECT FINANCIAL ASSISTANCE", "Base Obligation Date": "2020-10-13", "CFDA Number": "12.360", "Description": "COVID 19 CAPACITY EXPANSION FOR COVID-19 RESPONSE AND IN SUPPORT OF PUBLIC HEALTH EMERGENCIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2860e236-e11a-9c11-c2e9-fd85e187d4a4-C", "generated_internal_id": "ASST_NON_W911NF2130001_2100"}, {"internal_id": 98311398, "Award ID": "W911NF2030004", "Award Amount": 231785407.0, "Award Type": "OTHER REIMBURSABLE, CONTINGENT, INTANGIBLE, OR INDIRECT FINANCIAL ASSISTANCE", "Base Obligation Date": "2020-06-05", "CFDA Number": "12.360", "Description": "\"COVID-19\" TECHNOLOGY INVESTMENT AGREEMENT (32 CFR PART 37) DOMESTIC INDUSTRIAL BASE EXPANSION- ADVANCED MANUFACTURING VALIDATION AND DOMESTIC INDUSTRIAL BASE CAPACITY EXPANSION OF ADVANCED, HIGH-QUALITY VALOR GLASS TUBING AND VIALS/CARTRIDGES TO REDUCE SUPPLY CHAIN RISK AND ENSURE RAPID DELIVERY OF MEDICAL COUNTERMEASURES (MCMS) TO THE WARFIGHTER AND MCMS AND OTHER SUPPORTIVE THERAPIES TO PROTECT U.S. PUBLIC HEALTH IN RESPONSE TO THE COVID-19 PANDEMIC AND OTHER FUTURE PUBLIC HEALTH EMERGENCIES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "78f740eb-6c12-3689-da44-c0653982eb17-C", "generated_internal_id": "ASST_NON_W911NF2030004_2100"}, {"internal_id": 110822087, "Award ID": "W911NF2030003", "Award Amount": 0.0, "Award Type": "OTHER REIMBURSABLE, CONTINGENT, INTANGIBLE, OR INDIRECT FINANCIAL ASSISTANCE", "Base Obligation Date": "2020-08-19", "CFDA Number": "12.360", "Description": "COVID-19: OPERATION WARP SPEED", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9337707-8b3b-e88a-6b7d-008d26651a4b-C", "generated_internal_id": "ASST_NON_W911NF2030003_9763"}, {"internal_id": 98311397, "Award ID": "W911NF2030003", "Award Amount": 207639748.0, "Award Type": "OTHER REIMBURSABLE, CONTINGENT, INTANGIBLE, OR INDIRECT FINANCIAL ASSISTANCE", "Base Obligation Date": "2020-06-05", "CFDA Number": "12.360", "Description": "COVID-19: DEVELOPING A DOMESTIC CONTINENTAL U.S.-BASED HYBRID PHARMACEUTICAL VIAL", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9337707-8b3b-e88a-6b7d-008d26651a4b-C", "generated_internal_id": "ASST_NON_W911NF2030003_2100"}]